Audience Discussion: Aligning with Regulatory Guidelines: Strategies for Measurable Value for Regulatory Submissions
Time: 10:00 am
day: Day Two
Details:
- How can we measure PE to add value to regulatory submissions
- What should we be measuring? Are we measuring the wrong things?
- How do we innovate the way we are quantify the input from patient community in a way that regulatory bodies will accept
- Are there any roles that have been put out about engaging with patient advocacy stakeholders
